JnJ calls conference to analyze Q3 financial results on October 18
13 Oct '05
1 min read
Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m. (ET) on Tuesday, October 18, 2005, to review third-quarter results and provide an update on the medical devices and diagnostics businesses. Robert J. Darretta, Vice Chairman and Chief Financial Officer; Helen E. Short, Vice President, Investor Relations; Michael J. Dormer, Worldwide Chairman, Medical Devices, and Nicholas J. Valeriani, Worldwide Chairman, Cardiovascular Devices & Diagnostics, will be on the call.
World's leading comprehensive firm Johnson & Johnson is a broadly-based manufacturer of health care products, as well as a provider of related services. The development of the first ready-made, ready-to-use surgical dressings by Johnson & Johnson in the mid-1880s marked not only the birth of a company, but also the first practical application of the theory of antiseptic wound treatment.
marketing@alchempro.com
